Mar 27, 2008 ... Actemra (tocilizumab) is a monoclonal antibody under development by Roche for the treatment of rheumatoid arthritis. ...

Some of the newest biologic treatments for rheumatoid arthritis are monoclonal antibodies. What is a monoclonal antibody?

Apr 9, 2006 ... Remicade and Humira, two out of the three TNF inhibitors used to treat rheumatoid arthritis, are monoclonal antibodies. ...

BRMs can include monoclonal antibodies, interferon, interleukin-2, and various types of colony-stimulating factors (CSF, GM-CSF, G-CSF). ...

Humira, the third anti-TNF drug, has been approved to treat rheumatoid arthritis. Humira is first human monoclonal antibody.

Humira (adalimumab) is a human monoclonal antibody. ... Adalimumab (Humira) is a recombinant human IgG1 monoclonal antibody. It is the second U.S. marketed ...

Actemra (tocilizumab) is the first humanized interleukin-6 receptor-inhibiting monoclonal antibody being developed to treat rheumatoid arthritis. ...

Rituximab is a genetically engineered chimeric murine/human monoclonal antibody. It is the first monoclonal antibody to be used as a chemotherapeutic agent. ...

Remicade (infliximab) is a biologic response modifier, specifically a monoclonal antibody which binds to and blocks tumor necrosis factor alpha (TNF-alpha). ...

It is not felt to be related to antibody production to Enbrel. Enbrel is a fusion protien, not a monoclonal antibody. Remicade and Humira are both ...